Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

as grindeks - sitagliptin hydrochloride monohydrate - filmtablette - 25 mg - sitagliptin hydrochloride monohydrate 28.35 mg - sitagliptin

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

as grindeks - sitagliptin hydrochloride monohydrate - filmtablette - 50 mg - sitagliptin hydrochloride monohydrate 56.7 mg - sitagliptin

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

as grindeks - sitagliptin hydrochloride monohydrate - filmtablette - 100 mg - sitagliptin hydrochloride monohydrate 113.4 mg - sitagliptin

Europäische Union - Deutsch - EMA (European Medicines Agency)

accord healthcare s.l.u. - sitagliptin hydrochloride - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka, d.d. novo mesto - sitagliptin; metformin hydrochlorid - filmtablette - 50 mg - 1000 mg - sitagliptin 50 mg; metformin hydrochlorid 1000 mg - metformin and sitagliptin

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka, d.d. novo mesto - sitagliptin; metformin hydrochlorid - filmtablette - 50 mg - 850 mg - sitagliptin 50 mg; metformin hydrochlorid 850 mg - metformin and sitagliptin

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz - sitagliptin hydrochloride monohydrate; metformin hydrochlorid - filmtablette - 50 mg - 850 mg - sitagliptin hydrochloride monohydrate 56.685 mg; metformin hydrochlorid 850 mg - metformin and sitagliptin

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz - sitagliptin hydrochloride monohydrate; metformin hydrochlorid - filmtablette - 50 mg - 1000 mg - sitagliptin hydrochloride monohydrate 56.685 mg; metformin hydrochlorid 1000 mg - metformin and sitagliptin

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz - sitagliptin hydrochloride monohydrate; metformin hydrochlorid - filmtablette - 50 mg - 850 mg - sitagliptin hydrochloride monohydrate 56.7 mg; metformin hydrochlorid 850 mg - metformin and sitagliptin

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz - sitagliptin hydrochloride monohydrate; metformin hydrochlorid - filmtablette - 50 mg - 1000 mg - sitagliptin hydrochloride monohydrate 56.7 mg; metformin hydrochlorid 1000 mg - metformin and sitagliptin